254 related articles for article (PubMed ID: 11543687)
21. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
Hackling A; Ghosh R; Perachon S; Mann A; Höltje HD; Wermuth CG; Schwartz JC; Sippl W; Sokoloff P; Stark H
J Med Chem; 2003 Aug; 46(18):3883-99. PubMed ID: 12930150
[TBL] [Abstract][Full Text] [Related]
22. N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.
Banala AK; Levy BA; Khatri SS; Furman CA; Roof RA; Mishra Y; Griffin SA; Sibley DR; Luedtke RR; Newman AH
J Med Chem; 2011 May; 54(10):3581-94. PubMed ID: 21495689
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR
J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833
[TBL] [Abstract][Full Text] [Related]
24. A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors.
Dutta AK; Fei XS; Reith ME
Bioorg Med Chem Lett; 2002 Feb; 12(4):619-22. PubMed ID: 11844685
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands.
Cha MY; Choi BC; Kang KH; Pae AN; Choi KI; Cho YS; Koh HY; Lee HY; Jung D; Kong JY
Bioorg Med Chem Lett; 2002 May; 12(10):1327-30. PubMed ID: 11992769
[TBL] [Abstract][Full Text] [Related]
26. 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.
Hodgetts KJ; Kieltyka A; Brodbeck R; Tran JN; Wasley JW; Thurkauf A
Bioorg Med Chem; 2001 Dec; 9(12):3207-13. PubMed ID: 11711296
[TBL] [Abstract][Full Text] [Related]
27. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
Löber S; Hübner H; Utz W; Gmeiner P
J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580
[TBL] [Abstract][Full Text] [Related]
28. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.
Tu Z; Li S; Cui J; Xu J; Taylor M; Ho D; Luedtke RR; Mach RH
J Med Chem; 2011 Mar; 54(6):1555-64. PubMed ID: 21348515
[TBL] [Abstract][Full Text] [Related]
30. Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.
Biswas S; Zhang S; Fernandez F; Ghosh B; Zhen J; Kuzhikandathil E; Reith ME; Dutta AK
J Med Chem; 2008 Jan; 51(1):101-17. PubMed ID: 18072730
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.
Peng X; Wang Q; Mishra Y; Xu J; Reichert DE; Malik M; Taylor M; Luedtke RR; Mach RH
Bioorg Med Chem Lett; 2015 Feb; 25(3):519-23. PubMed ID: 25556097
[TBL] [Abstract][Full Text] [Related]
32. Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists.
Bettinetti L; Schlotter K; Hübner H; Gmeiner P
J Med Chem; 2002 Oct; 45(21):4594-7. PubMed ID: 12361386
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
Insua I; Alvarado M; Masaguer CF; Iglesias A; Brea J; Loza MI; Carro L
Bioorg Med Chem Lett; 2013 Oct; 23(20):5586-91. PubMed ID: 24012118
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse.
Mason CW; Hassan HE; Kim KP; Cao J; Eddington ND; Newman AH; Voulalas PJ
J Pharmacol Exp Ther; 2010 Jun; 333(3):854-64. PubMed ID: 20228156
[TBL] [Abstract][Full Text] [Related]
36. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
[TBL] [Abstract][Full Text] [Related]
37. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.
Haubmann C; Hübner H; Gmeiner P
Bioorg Med Chem Lett; 1999 Jul; 9(14):1969-72. PubMed ID: 10450964
[TBL] [Abstract][Full Text] [Related]
38. Bivalent molecular probes for dopamine D2-like receptors.
Huber D; Löber S; Hübner H; Gmeiner P
Bioorg Med Chem; 2012 Jan; 20(1):455-66. PubMed ID: 22100258
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, lipophilic properties, and binding affinities of potential ligands in positron emission tomography (PET) for visualization of brain dopamine D4 receptors.
Lacivita E; De Giorgio P; Colabufo NA; Berardi F; Perrone R; Niso M; Leopoldo M
Chem Biodivers; 2014 Feb; 11(2):299-310. PubMed ID: 24591318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
